advanced hepatocellular carcinoma (hcc)
Showing 1 - 11 of 11
HepaSphere Drug-eluting Bead Transarterial Chemoembolization
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- DEB-TACE plus HAIC or HAIC alone
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 19, 2023
Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- +2 more
-
Duarte, California
- +2 more
Aug 29, 2022
Advanced Hepatocellular Carcinoma (HCC) Trial in China, Singapore (Toripalimab combined with Bevacizumab, Sorafenib)
Active, not recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- Toripalimab combined with Bevacizumab
- Sorafenib
-
Bengbu, Anhui, China
- +55 more
Jun 22, 2022
Advanced Hepatocellular Carcinoma (HCC) Trial in Hong Kong (MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate)
Terminated
- Advanced Hepatocellular Carcinoma (HCC)
- MGD013 monotherapy
- MGD013 in combination with Brivanib Alaninate
-
Hong Kong, Hong Kong, ChinaPrince of Wales Hospital
Jun 8, 2022
ADVANCED HEPATOCELLULAR CARCINOMA (HCC) Trial in Philadelphia (Galunisertib 150mg by mouth twice a day, Stereotactic Body
Completed
- ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
- Galunisertib 150mg by mouth twice a day
- Stereotactic Body Radiotherapy (SBRT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 10, 2022
Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (Toripalimab combined with Bevacizumab)
Active, not recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- Toripalimab combined with Bevacizumab
-
Beijing, ChinaBeijing Cancer hospital
Nov 22, 2021
Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)
Enrolling by invitation
- Advanced Hepatocellular Carcinoma (HCC)
- camrelizumab;Rivoceranib
- +3 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Oct 21, 2021
Advanced Hepatocellular Carcinoma (HCC) Trial in China (AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate
Not yet recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- AK105 Injection
- +2 more
-
Bengbu, Anhui, China
- +42 more
Apr 13, 2020
Advanced Hepatocellular Carcinoma (HCC) Trial in Taipei (Axitinib, Radiation)
Completed
- Advanced Hepatocellular Carcinoma (HCC)
- Axitinib
- Radiation
-
Taipei, TaiwanShin Kong Wu Ho-Su Memorial Hospital
Sep 19, 2019
Advanced Hepatocellular Carcinoma (HCC) Trial in Worldwide (OSI-906, Placebo)
Terminated
- Advanced Hepatocellular Carcinoma (HCC)
- OSI-906
- Placebo
-
Los Angeles, California
- +40 more
Aug 31, 2018
Advanced Hepatocellular Carcinoma (HCC) Trial in Dalian (TAE plus P53 gene, TAE)
Unknown status
- Advanced Hepatocellular Carcinoma (HCC)
- TAE plus P53 gene
- TAE
-
Dalian, Liaoning, Chinafirst affiliated hospital in Dalian University
Jul 23, 2015